Actively Recruiting
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
Led by Yang Xiaotian · Updated on 2024-08-02
50
Participants Needed
1
Research Sites
351 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a clinical efficacy study evaluating the VAG regimen in the treatment of newly diagnosed acute myeloid leukemia (AML). The main objectives of the study are to assess the efficacy and safety of the VAG regimen and to explore the synergistic mechanisms of VAG in combating AML.
CONDITIONS
Official Title
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years, regardless of gender.
- Diagnosis of AML (excluding APL) according to the 2022 WHO diagnostic criteria.
- ECOG performance status of 0-2.
- Effective contraception for females of childbearing potential and males with female partners during treatment and for 6 months after.
- Expected survival of at least 3 months.
- Ability to understand and willingness to participate, with signed informed consent.
You will not qualify if you...
- Acute promyelocytic leukemia (M3 subtype).
- Central nervous system leukemia.
- Severe uncontrolled infection or other major diseases.
- Heart failure with ejection fraction less than 50% or NYHA class II or above.
- Impaired liver or kidney function defined by specific laboratory values.
- HIV positive.
- Active hepatitis B or C.
- Pregnant or lactating women.
- Other conditions deemed unsuitable by the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Huai'an Second People's Hospital
Huai'an, Jiangsu, China, 210000
Actively Recruiting
Research Team
X
Xiaotian Yang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here